Yayınlanmış 1 Ocak 2014
| Sürüm v1
Dergi makalesi
Açık
Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy
Oluşturanlar
- 1. Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England
Açıklama
Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.
Dosyalar
bib-14a98927-83cc-446d-b748-689d784c46ab.txt
Dosyalar
(249 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:811b964c4591961d629fc94224552a3a
|
249 Bytes | Ön İzleme İndir |